Please use this identifier to cite or link to this item:
標題: A型流行性感冒病毒非結構蛋白1A在活細胞分佈情形之研究
Intracellular localization of influenza virus A/PR/8/34 NS1A protein in live cells
作者: 蔡傳馥
Tsai, Chuan-Fu
關鍵字: influenza virus
live cells
出版社: 生物科技學研究所
引用: Adams, S. R., Campbell, R. E., Gross, L. A., Martin, B. R., Walkup, G. K., Yao, Y., Llopis, J., and Tsien, R. Y. (2002). New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc 124(21), 6063-76. Alonso-Caplen, F. V., and Krug, R. M. (1991). Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA. Mol Cell Biol 11(2), 1092-8. Alonso-Caplen, F. V., Nemeroff, M. E., Qiu, Y., and Krug, R. M. (1992). Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev 6(2), 255-67. Arhel, N., Genovesio, A., Kim, K. A., Miko, S., Perret, E., Olivo-Marin, J. C., Shorte, S., and Charneau, P. (2006). Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods 3(10), 817-24. Barman, S., and Nayak, D. P. (2000). Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. J Virol 74(14), 6538-45. Bornholdt, Z. A., and Prasad, B. V. (2006). X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13(6), 559-60. Bornholdt, Z. A., and Prasad, B. V. (2008). X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456(7224), 985-8. Bourmakina, S. V., and Garcia-Sastre, A. (2003). Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol 84(Pt 3), 517-27. Bui, M., Wills, E. G., Helenius, A., and Whittaker, G. R. (2000). Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74(4), 1781-6. Burleigh, L. M., Calder, L. J., Skehel, J. J., and Steinhauer, D. A. (2005). Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol 79(2), 1262-70. Carr, S. M., Carnero, E., Garcia-Sastre, A., Brownlee, G. G., and Fodor, E. (2006). Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344(2), 492-508. Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O''Neill, R., Schickli, J., Palese, P., Henklein, P., Bennink, J. R., and Yewdell, J. W. (2001). A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7(12), 1306-12. Chen, Z., Li, Y., and Krug, R. M. (1999). Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3''-end processing machinery. EMBO J 18(8), 2273-83. Chien, C. Y., Tejero, R., Huang, Y., Zimmerman, D. E., Rios, C. B., Krug, R. M., and Montelione, G. T. (1997). A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol 4(11), 891-5. Chu, C. M., Dawson, I. M., and Elford, W. J. (1949). Filamentous forms associated with newly isolated influenza virus. Lancet 1(6554), 602. Compans, R. W., Meier-Ewert, H., and Palese, P. (1974). Assembly of lipid-containing viruses. J Supramol Struct 2(2-4), 496-511. Connor, R. J., Kawaoka, Y., Webster, R. G., and Paulson, J. C. (1994). Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205(1), 17-23. Das, S. C., Panda, D., Nayak, D., and Pattnaik, A. K. (2009). Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol 83(6), 2611-22. Dawood, F. S., Jain, S., Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., Gubareva, L. V., Xu, X., Bridges, C. B., and Uyeki, T. M. (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360(25), 2605-15. de Wit, E., Spronken, M. I., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D., and Fouchier, R. A. (2004). Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res 103(1-2), 155-61. Donelan, N. R., Basler, C. F., and Garcia-Sastre, A. (2003). A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77(24), 13257-66. Elleman, C. J., and Barclay, W. S. (2004). The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321(1), 144-53. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., and Garcia-Sastre, A. (1999). Rescue of influenza A virus from recombinant DNA. J Virol 73(11), 9679-82. Fouchier, R. A., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B., and Osterhaus, A. D. (2005). Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79(5), 2814-22. Gaietta, G., Deerinck, T. J., Adams, S. R., Bouwer, J., Tour, O., Laird, D. W., Sosinsky, G. E., Tsien, R. Y., and Ellisman, M. H. (2002). Multicolor and electron microscopic imaging of connexin trafficking. Science 296(5567), 503-7. Garaigorta, U., Falcon, A. M., and Ortin, J. (2005). Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol 79(24), 15246-57. Garaigorta, U., and Ortin, J. (2007). Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA. Nucleic Acids Res 35(14), 4573-82. Garcia-Sastre, A., Muster, T., Barclay, W. S., Percy, N., and Palese, P. (1994). Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J Virol 68(10), 6254-61. Greenspan, D., Palese, P., and Krystal, M. (1988). Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62(8), 3020-6. Griffin, B. A., Adams, S. R., and Tsien, R. Y. (1998). Specific covalent labeling of recombinant protein molecules inside live cells. Science 281(5374), 269-72. Hale, B. G., Barclay, W. S., Randall, R. E., and Russell, R. J. (2008). Structure of an avian influenza A virus NS1 protein effector domain. Virology 378(1), 1-5. Hatada, E., and Fukuda, R. (1992). Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73 ( Pt 12), 3325-9. Hatada, E., Saito, S., Okishio, N., and Fukuda, R. (1997). Binding of the influenza virus NS1 protein to model genome RNAs. J Gen Virol 78 ( Pt 5), 1059-63. Hayman, A., Comely, S., Lackenby, A., Murphy, S., McCauley, J., Goodbourn, S., and Barclay, W. (2006). Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347(1), 52-64. Hoffmann, E., Neumann, G., Hobom, G., Webster, R. G., and Kawaoka, Y. (2000a). "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267(2), 310-7. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., and Webster, R. G. (2000b). A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97(11), 6108-13. Honda, A., Ueda, K., Nagata, K., and Ishihama, A. (1987). Identification of the RNA polymerase-binding site on genome RNA of influenza virus. J Biochem 102(5), 1241-9. Kawaoka Y., C., N.J., Haller, O., Hongo, S., Kaverin, N., Klenk, H.-D., Lamb, R.A., McCauley, J., Palese, P., Rimstad E. and Webster, R.G. (2005). "Orthomyxoviridae." Virus Taxonomy: Classification and Nomenclature of Viruses, Eighth Report of the International Committe on the Taxonomy of Viruses (M. A. M. C.M. Fauquet, J. Maniloff, U. Desselberger and L.A. Ball, Ed.). Kochs, G., Garcia-Sastre, A., and Martinez-Sobrido, L. (2007). Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81(13), 7011-21. Krug, R. M. (1981). Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol 93, 125-49. Krug, R. M., and Etkind, P. R. (1973). Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology 56(1), 334-48. Lamb, R. A., and Choppin, P. W. (1979). Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A 76(10), 4908-12. Lamb, R. A., and Choppin, P. W. (1981). Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology 112(2), 729-37. Lamb, R. A., and Lai, C. J. (1980). Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21(2), 475-85. Lanman, J., Crum, J., Deerinck, T. J., Gaietta, G. M., Schneemann, A., Sosinsky, G. E., Ellisman, M. H., and Johnson, J. E. (2008). Visualizing flock house virus infection in Drosophila cells with correlated fluorescence and electron microscopy. J Struct Biol 161(3), 439-46. Latham, T., and Galarza, J. M. (2001). Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 75(13), 6154-65. Li, S., Min, J. Y., Krug, R. M., and Sen, G. C. (2006). Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349(1), 13-21. Li, X., and Palese, P. (1994). Characterization of the polyadenylation signal of influenza virus RNA. J Virol 68(2), 1245-9. Li, Y., Yamakita, Y., and Krug, R. M. (1998). Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A 95(9), 4864-9. Lin, S.-Y. (2008). National Chung Hsing University, Taichung. Lin, S., Naim, H. Y., Rodriguez, A. C., and Roth, M. G. (1998). Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. J Cell Biol 142(1), 51-7. Liu, J., Lynch, P. A., Chien, C. Y., Montelione, G. T., Krug, R. M., and Berman, H. M. (1997). Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol 4(11), 896-9. Luo, G. X., Luytjes, W., Enami, M., and Palese, P. (1991). The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol 65(6), 2861-7. Luytjes, W., Krystal, M., Enami, M., Parvin, J. D., and Palese, P. (1989). Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59(6), 1107-13. Marek, K. W., and Davis, G. W. (2002). Transgenically encoded protein photoinactivation (FlAsH-FALI): acute inactivation of synaptotagmin I. Neuron 36(5), 805-13. Marion, R. M., Aragon, T., Beloso, A., Nieto, A., and Ortin, J. (1997). The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res 25(21), 4271-7. Martin, K., and Helenius, A. (1991). Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65(1), 232-44. Matlin, K. S., Reggio, H., Helenius, A., and Simons, K. (1981). Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91(3 Pt 1), 601-13. McLean, J. E., Datan, E., Matassov, D., and Zakeri, Z. F. (2009). Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J Virol 83(16), 8233-46. Melen, K., Kinnunen, L., Fagerlund, R., Ikonen, N., Twu, K. Y., Krug, R. M., and Julkunen, I. (2007). Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 81(11), 5995-6006. Min, J. Y., and Krug, R. M. (2006). The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2''-5'' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103(18), 7100-5. Min, J. Y., Li, S., Sen, G. C., and Krug, R. M. (2007). A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363(1), 236-43. Murayama, R., Harada, Y., Shibata, T., Kuroda, K., Hayakawa, S., Shimizu, K., and Tanaka, T. (2007). Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional protein nucleolin during infection. Biochem Biophys Res Commun 362(4), 880-5. Murti, K. G., Brown, P. S., Bean, W. J., Jr., and Webster, R. G. (1992). Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy. Virology 186(1), 294-9. Nayak, D. P., Hui, E. K., and Barman, S. (2004). Assembly and budding of influenza virus. Virus Res 106(2), 147-65. Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W., and Krug, R. M. (1998). Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3''end formation of cellular pre-mRNAs. Mol Cell 1(7), 991-1000. Neumann, G., Brownlee, G. G., Fodor, E., and Kawaoka, Y. (2004). Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 283, 121-43. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., Hobom, G., and Kawaoka, Y. (1999). Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96(16), 9345-50. Newby, C. M., Sabin, L., and Pekosz, A. (2007). The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol 81(17), 9469-80. O''Neill, R. E., Jaskunas, R., Blobel, G., Palese, P., and Moroianu, J. (1995). Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270(39), 22701-4. O''Neill, R. E., Talon, J., and Palese, P. (1998). The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 17(1), 288-96. Palese, P., and Compans, R. W. (1976). Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 33(1), 159-63. Palese, P., and Shaw, M. L. (2007). "Orthomyxoviridae: the viruses and their replication." 5th ed. Fields Virology (D. M. Knipe, and P. M. Howley, Eds.) Lippincott Willian & Wilkins, Philadelphia. Panchal, R. G., Ruthel, G., Kenny, T. A., Kallstrom, G. H., Lane, D., Badie, S. S., Li, L., Bavari, S., and Aman, M. J. (2003). In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A 100(26), 15936-41. Parvin, J. D., Palese, P., Honda, A., Ishihama, A., and Krystal, M. (1989). Promoter analysis of influenza virus RNA polymerase. J Virol 63(12), 5142-52. Pinto, L. H., Holsinger, L. J., and Lamb, R. A. (1992). Influenza virus M2 protein has ion channel activity. Cell 69(3), 517-28. Presti, R. M., Zhao, G., Beatty, W. L., Mihindukulasuriya, K. A., da Rosa, A. P., Popov, V. L., Tesh, R. B., Virgin, H. W., and Wang, D. (2009). Quaranfil, Johnston Atoll, and Lake Chad viruses are novel members of the family Orthomyxoviridae. J Virol 83(22), 11599-606. Qian, X. Y., Chien, C. Y., Lu, Y., Montelione, G. T., and Krug, R. M. (1995). An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1(9), 948-56. Qiu, Y., Nemeroff, M., and Krug, R. M. (1995). The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1(3), 304-16. Richardson, J. C., and Akkina, R. K. (1991). NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch Virol 116(1-4), 69-80. Rudner, L., Nydegger, S., Coren, L. V., Nagashima, K., Thali, M., and Ott, D. E. (2005). Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling. J Virol 79(7), 4055-65. Schmitt, A. P., and Lamb, R. A. (2005). Influenza virus assembly and budding at the viral budozone. Adv Virus Res 64, 383-416. Shimizu, K., Iguchi, A., Gomyou, R., and Ono, Y. (1999). Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Virology 254(2), 213-9. Sieczkarski, S. B., and Whittaker, G. R. (2002). Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol 76(20), 10455-64. Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., and Schonberger, L. B. (1997). The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 87(12), 1944-50. Stegmann, T. (2000). Membrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion. Traffic 1(8), 598-604. Tan, S. L., and Katze, M. G. (1998). Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18(9), 757-66. Tour, O., Meijer, R. M., Zacharias, D. A., Adams, S. R., and Tsien, R. Y. (2003). Genetically targeted chromophore-assisted light inactivation. Nat Biotechnol 21(12), 1505-8. Tsien, R. Y. (2005). Building and breeding molecules to spy on cells and tumors. FEBS Lett 579(4), 927-32. Twu, K. Y., Kuo, R. L., Marklund, J., and Krug, R. M. (2007). The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81(15), 8112-21. Wang, W., Riedel, K., Lynch, P., Chien, C. Y., Montelione, G. T., and Krug, R. M. (1999). RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5(2), 195-205. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., and Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56(1), 152-79. Yamada, H., Chounan, R., Higashi, Y., Kurihara, N., and Kido, H. (2004). Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578(3), 331-6. Zamarin, D., Garcia-Sastre, A., Xiao, X., Wang, R., and Palese, P. (2005). Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1(1), e4. Zhang, J., Campbell, R. E., Ting, A. Y., and Tsien, R. Y. (2002). Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol 3(12), 906-18. Zhirnov, O. P., Konakova, T. E., Wolff, T., and Klenk, H. D. (2002). NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76(4), 1617-25.
摘要: A型流行性感冒病毒屬於正黏液病毒屬,具有八條單股負極性分節的核醣核酸基因體,可轉錄出十一個病毒蛋白質。其中第八條分節的核醣核酸基因體可以轉譯出兩個病毒非結構性蛋白質,NS1A和NEP。前人研究發現A型流行性感冒病毒NS1蛋白質在病毒感染時具有許多功能,主要扮演抑制細胞中免疫反應以及訊息核醣核酸的成熟和出核,並且幫助病毒基因體的複製與轉譯。在本論文的研究中,為了能夠即時觀測在病毒感染時NS1A的分佈,我們在NS1A蛋白質核酸結合區域與因子結合區域間之連接區段接合tetracysteine-tag,再利用逆向遺傳系統 (reverse genetic system)生產出病毒,經由病毒感染細胞後,以FlAsH螢光標定,利用共軛焦顯微鏡觀測NS1A在活細胞中分佈情形。經過逆向遺傳系統產生的突變株病毒 (NS1-tc-linker virus),在感染細胞後可以利用西方點墨法確認NS1A蛋白質在病毒感染的細胞中的表現量,與野生型病毒之NS1A的表現量相似。並且利用融菌斑試驗確認突變株病毒具有和野生型病毒相似的感染力價。在試管內FlAsH螢光接合試驗中,突變株病毒之NS1A蛋白質能有效率且具有專一性的與FlAsH結合。將突變株病毒感染細胞後,以FlAsH螢光標定,再利用NS1A抗體進行免疫螢光染色觀察NS1A蛋白質在細胞中的分佈情形,證實FlAsH螢光的位置與利用抗體標定之NS1A蛋白質位置具有相同的分佈情形。最後利用共軛焦顯微鏡觀測經過病毒感染的細胞中,被FlAsH標定的NS1A蛋白質的分佈,發現在病毒感染1.5小時後,NS1A蛋白質會分佈於粒線體中;而在感染後4小時與8小時,NS1A蛋白質則會主要分佈在細胞核並且形成類似核仁的螢光亮點。本研究中建立了利用FlAsH螢光標定,在病毒感染的過程中,病毒蛋白質在活細胞的分佈情形,將成為深入了解病毒生活史的有利工具。
The influenza A viruses are the prototype of the family Orthomyxoviridae. They contain eight single-stranded, negative-sense, segmented viral RNA (vRNA), which encode 11 known proteins. The vRNA segment eight encodes two nonstructural proteins, NS1A and NEP. The NS1 protein is a multifunctional protein that counteracts host cell antiviral responses and inhibits host cell pre-mRNA processing. In order to study the dynamics of localization of NS1 protein during virus infection in live cells, tetracysteine-tag (TC-tag) which can bind the membrane permeable bis-arsenical fluorescein FlAsH with fluorescent was fused with NS1 at the linker region between RNA-binding domain and effector domain and the loop region inside the effector domain. The construct containing TC-tag at the linker region of NS1A is cotransfected with all other plasmids of reverse genetic system into 293 cells to generate the recombinant virus. The mutant virus shows similar the infectivity with that of wild type. In vitro labeling the mutant NS1-tc-linker protein with FlAsH was successful and specific. The specific localization of NS1 in infected cells can be visualized after FlAsH labeling by confocal microscopy. NS1 was found to localize in mitochondria at very early time point of infection (1.5 hpi); and at 4 hpi and 8hpi, it was localized predominantly in nucleus at 4 hpi and 8 hpi and formed a granular pattern. These results suggested that the biarsenical labeling technique is successfully established and it can be an important strategy to visualize the location of target proteins dynamically in live cell.
其他識別: U0005-2701201003073400
Appears in Collections:生物科技學研究所



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.